Specific microRNA expression during chondrogenesis of human mesenchymal stem cells

International Journal of Molecular Medicine

Volumn 25, Issue 3, 2010, Pages 377-384

  Han, Jianwei ^a   Yang, Tongtao ^a   Gao, Jie ^a   Wu, Jiachang ^a   Qiu, Xiuchun ^a   Fan, Qingyu ^a   Ma, Baoan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Differentiation; Mesenchymal stem cell; Microarray; MicroRNA

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CARTILAGE INTERMEDIATE LAYER PROTEIN; CHONDROITIN 6 SULFOTRANSFERASE 3; CHONDROITIN SULFATE SYNTHASE 1; COLLAGEN; COLLAGEN TYPE 10; COLLAGEN TYPE 10ALPHA1; COLLAGEN TYPE 19ALPHA1; COLLAGEN TYPE 2; COLLAGEN TYPE 2ALPHA1; COLLAGEN TYPE 4; COLLAGEN TYPE 4ALPHA1; COLLAGEN TYPE 6; COLLAGEN TYPE 6ALPHA1; GENE PRODUCT; MICRORNA; OSTEOGENIN; SMAD1 PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; SULFOTRANSFERASE; SYNTHETASE; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, CD; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MESENCHYMAL STEM CELLS; MICROARRAY ANALYSIS; MICRORNAS; YOUNG ADULT;

EID: 76949104444     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000355     Document Type: Article

References (56)

1. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L and Verfaillie CM: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 2615-2625, 2001.
2. Jiang Y, Jahagirdar BN, Reinhardt RL, et al: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49, 2002.
3. Tocci A and Forte L: Mesenchymal stem cell: use and perspectives. Hematol J 4: 92-96, 2003.
4. Le Blanc K and Pittenger M: Mesenchymal stem cells: progress toward promise. Cytotherapy 7: 36-45, 2005.
5. Goff LA, Boucher S, Ricupero CL, et al: Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: prediction of microRNA regulation by PDGF during osteogenesis. Exp Hematol 36: 1354-1369, 2008.
6. Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006.
7. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
8. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993.
9. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell 115: 787-798, 2003.
10. Wienholds E, Kloosterman WP, Miska E, et al: MicroRNA expression in zebrafish embryonic development. Science 309: 310-311, 2005.
11. Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW and Ruohola-Baker H: Stem cell division is regulated by the microRNA pathway. Nature 435: 974-978, 2005.
12. Esau C, Kang X, Peralta E, et al: MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279: 52361-52365, 2004.
13. Zhao Y, Samal E and Srivastava D: Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436: 214-220, 2005.
14. Kuwabara T, Hsieh J, Nakashima K, Taira K and Gage FH: A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell 116: 779-793, 2004.
15. Chen CZ, Li L, Lodish HF and Bartel DP: MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86, 2004.
16. Tang F, Hajkova P, Barton SC, Lao K and Surani MA: MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 34: E9, 2006.
17. Chen YJ, Min J, Shang CZ, et al: MicroRNA differential expression profile during differentiation of embryonic stem cells towards hepatocytes induced by sodium butyrate. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 30: 469-473, 2008.
18. Ivey KN, Muth A, Arnold J, et al: MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2: 219-229, 2008.
19. Houbaviy HB, Murray MF and Sharp PA: Embryonic stem cell-specific MicroRNAs. Dev Cell 5: 351-358, 2003.
20. Suh MR, Lee Y, Kim JY, et al: Human embryonic stem cells express a unique set of microRNAs. Dev Biol 270: 488-498, 2004.
21. Mizuno Y, Yagi K, Tokuzawa Y, et al: miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 368: 267-272, 2008.
22. Tuddenham L, Wheeler G, Ntounia-Fousara S, et al: The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett 580: 4214-4217, 2006.
23. Yan N, Lu Y, Sun H, et al: A microarray for microRNA profiling in mouse testis tissues. Reproduction 134: 73-79, 2007.
24. Liao R, Sun J, Zhang L, et al: MicroRNAs play a role in the development of human hematopoietic stem cells. J Cell Biochem 104: 805-817, 2008.
25. Thomson JM, Parker J, Perou CM and Hammond SM: A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1: 47-53, 2004.
26. He H, Jazdzewski K, Li W, et al: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080, 2005.
27. Chen C, Ridzon DA, Broomer AJ, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: E179, 2005.
28. Schmittgen TD, Jiang J, Liu Q and Yang L: A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res 32: E43, 2004.
29. Rajewsky N and Socci ND: Computational identification of microRNA targets. Dev Biol 267: 529-535, 2004.
30. Krek A, Grun D, Poy MN, et al: Combinatorial microRNA target predictions. Nat Genet 37: 495-500, 2005.
31. John B, Enright AJ, Aravin A, Tuschl T, Sander C and Marks DS: Human MicroRNA targets. PLoS Biol 2: E363, 2004.
32. Dominici M, Le Blanc K, Mueller I, et al: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317, 2006.
33. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999.
34. Wagner W, Wein F, Seckinger A, et al: Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416, 2005.
35. Barad O, Meiri E, Avniel A, et al: MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res 14: 2486-2494, 2004.
36. Lakshmipathy U and Hart RP: Concise review: MicroRNA expression in multipotent mesenchymal stromal cells. Stem Cells 26: 356-363, 2008.
37. Ohgawara T, Kubota S, Kawaki H, et al: Regulation of chondrocytic phenotype by micro RNA 18a: involvement of Ccn2/Ctgf as a major target gene. FEBS Lett 583: 1006-1010, 2009.
38. Lin EA, Kong L, Bai XH, Luan Y and Liu CJ: miR-199a, a bone morphogenic protein 2 responsive microRNA, regulates chondrogenesis via direct targeting to Smad1. J Biol Chem 284: 11326-11335, 2009.
39. Bentwich I: Prediction and validation of microRNAs and their targets. FEBS Lett 579: 5904-5910, 2005.
40. Structural and contractile proteins. Part D. Extracellular matrix. Methods Enzymol 144: 1-561, 1987.
41. Linsenmayer TF, Long F, Nurminskaya M, Chen Q and Schmid TM: Type X collagen and other up-regulated components of the avian hypertrophic cartilage program. Prog Nucleic Acid Res Mol Biol 60: 79-109, 1998.
42. Rosati R, Horan GS, Pinero GJ, et al: Normal long bone growth and development in type X collagen-null mice. Nat Genet 8: 129-135, 1994.
43. Kwan KM, Pang MK, Zhou S, et al: Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function. J Cell Biol 136: 459-471, 1997.
44. Jacenko O, Chan D, Franklin A, et al: A dominant interference collagen X mutation disrupts hypertrophic chondrocyte pericellular matrix and glycosaminoglycan and proteoglycan distribution in transgenic mice. Am J Pathol 159: 2257-2269, 2001.
45. Warman ML, Abbott M, Apte SS, et al: A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet 5: 79-82, 1993.
46. Chan D and Jacenko O: Phenotypic and biochemical consequences of collagen X mutations in mice and humans. Matrix Biol 17: 169-184, 1998.
47. Tsumaki N and Yoshikawa H: The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev 16: 279-285, 2005.
48. Wozney JM: The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult. Eur J Oral Sci 106 (Suppl 1): 160-166, 1998.
49. Hermanns P, Unger S, Rossi A, et al: Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. Am J Hum Genet 82: 1368-1374, 2008.
50. Thiele H, Sakano M, Kitagawa H, et al: Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement. Proc Natl Acad Sci USA 101: 10155-10160, 2004.
51. Kitagawa H, Izumikawa T, Uyama T and Sugahara K: Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization. J Biol Chem 278: 23666-23671, 2003.
52. Kawashima H, Atarashi K, Hirose M, et al: Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/ IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J Biol Chem 277: 12921-12930, 2002.
53. Morgenstern DA, Asher RA and Fawcett JW: Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res 137: 313-332, 2002.
54. Bechard D, Gentina T, Delehedde M, et al: Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem 276: 48341-48349, 2001.
55. Lorenzo P, Bayliss MT and Heinegard D: A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem 273: 23463-23468, 1998.
56. Longobardi L, O'Rear L, Aakula S, et al: Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 21: 626-636, 2006.